text
"['\n1. 요약재무정보\n1) 요약 연결재무제표\n(주)에이프로젠(코스피 상장사, 前 (주)에이프로젠메디신) 과 그 종속기업\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 52(당분기)\n제 51(전)기\n제 50(전전)기\n1. 요약 재무상태표\n(2022년 09월 30일 현재)\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n[유동자산]\n221,933,591,527\n103,099,363,353\n84,880,562,684\n\xa0 현금및현금성자산(\n54,627,017,572\n15,893,503,873\n3,021,932,681\n\xa0 매출채권및기타유동채권\n93,315,724,257\n56,990,094,596\n47,266,832,779\n\xa0 기타유동금융자산\n5,390,000,000\n4,000,000,000\n15,150,000,000\n\xa0 재고자산\n59,950,102,673\n23,257,262,751\n16,982,190,175\n\xa0 기타유동자산\n5,374,024,687\n2,366,947,893\n1,496,095,369\n\xa0 당기법인세자산\n3,276,722,338\n591,554,240\n963,511,680\n[비유동자산]\n391,176,013,753\n374,547,035,232\n381,279,492,834\n\xa0 기타비유동채권\n3,646,454,223\n2,361,211,951\n1,748,954,880\n\xa0 기타비유동금융자산\n4,964,948,213\n20,745,377,859\n31,895,222,981\n\xa0 관계기업 투자주식\n1,230,872,368\n34,040,936,160\n41,146,839,680\n\xa0 유형자산\n360,993,211,304\n314,479,014,477\n305,355,380,590\n\xa0 무형자산\n13,762,516,456\n2,633,095,260\n891,692,168\n\xa0 투자부동산\n5,839,104,304\n57,686,814\n58,910,061\n\xa0 기타비유동자산\n187,685,337\n229,712,711\n182,492,474\n\xa0 이연법인세자산\n551,221,548\n-\n-\n자 산 총 계\n613,109,605,280\n477,646,398,585\n466,160,055,518\n[유동부채]\n73,924,779,226\n421,928,721,268\n327,034,098,754\n[비유동부채]\n48,739,660,420\n56,524,120,087\n26,283,029,818\n부 채 총 계\n122,664,439,646\n478,452,841,355\n353,317,128,572\n[지배기업의 소유주지분]\n116,834,562,882\n2,163,178,265\n90,473,990,711\n\xa0 자본금\n380,503,283,500\n260,351,437,000\n25,900,916,000\n\xa0 자본잉여금\n177,213,386,088\n46,794,485,822\n156,117,948,723\n\xa0 기타자본구성요소\n(177,285,640,492)\n(113,403,240,100)\n6,696,445,228\n\xa0 기타포괄손익누계액\n3,108,253,467\n886,575,619\n475,669,195\n\xa0 이익잉여금(결손금)\n(266,704,719,681)\n(192,466,080,076)\n(98,716,988,435)\n[비지배지분]\n373,610,602,752\n(2,969,621,035)\n22,368,936,235\n자 본 총 계\n490,445,165,634\n(806,442,770)\n112,842,926,946\n2. 요약 포괄손익계산서\n(2022.1.1~2022.9.30)\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n매출액\n41,267,411,395\n20,482,768,426\n24,893,956,731\n영업이익(손실)\n(94,593,975,486)\n(69,066,165,912)\n(71,242,537,984)\n당기순이익(손실)\n(86,038,163,711)\n(87,957,994,202)\n(112,117,595,937)\n- 지배기업소유주지분순이익(손실)\n(74,663,718,111)\n(69,654,304,403)\n(86,342,861,659)\n- 비지배지분순이익(손실)\n(11,374,445,600)\n(18,303,689,799)\n(25,774,734,278)\n기본주당순이익(손실)\n(131)\n(134)\n(1,668)\n희석주당순이익(손실)\n(131)\n(134)\n(1,668)\n연결에 포함된 회사 수\n9\n2\n2\n2) 요약 별도재무제표\n(주)에이프로젠(코스피 상장사, 前 (주)에이프로젠메디신)\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 52(당분기)\n제 51(전)기\n제 50(전전)기\n1. 요약 재무상태표\n(2022년 09월 30일 현재)\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n[유동자산]\n181,241,864,741\n26,082,180,411\n42,248,774,600\n\xa0 현금및현금성자산\n37,680,238,692\n10,148,420,282\n770,976,304\n\xa0 매출채권및기타유동채권\n127,318,390,374\n10,334,726,806\n21,890,377,453\n\xa0 기타유동금융자산\n4,000,000,000\n4,000,000,000\n15,150,000,000\n\xa0 재고자산\n8,682,589,005\n83,916,352\n2,432,268,745\n\xa0 기타유동자산\n3,328,868,122\n1,336,473,131\n2,005,152,098\n\xa0 당기법인세자산\n231,778,548\n178,643,840\n949,520,040\n[비유동자산]\n449,871,007,474\n180,143,086,542\n162,900,567,620\n\xa0 기타비유동채권\n2,249,669,286\n1,673,470,701\n1,508,994,880\n\xa0 공정가치측정금융자산\n530,123,142\n20,745,377,859\n31,895,222,981\n\xa0 종속기업 투자주식\n303,385,426,944\n101,056,306,494\n64,165,542,059\n\xa0 관계기업 투자주식\n-\n34,040,936,160\n41,146,839,680\n\xa0 유형자산\n42,679,291,674\n22,029,697,305\n23,423,799,867\n\xa0 무형자산\n98,741,293,725\n309,898,498\n518,765,618\n\xa0 투자부동산\n2,116,329,730\n57,686,814\n58,910,061\n\xa0 기타비유동자산\n168,872,973\n229,712,711\n182,492,474\n자산총계\n631,112,872,215\n206,225,266,953\n205,149,342,220\n[유동부채]\n256,315,184,026\n62,009,526,849\n80,671,525,544\n[비유동부채]\n38,320,691,429\n33,856,803,504\n2,776,530,711\n부채총계\n294,635,875,455\n95,866,330,353\n83,448,056,255\n\xa0 자본금\n380,503,283,500\n260,351,437,000\n25,900,916,000\n\xa0 자본잉여금\n134,591,074,112\n4,172,827,662\n113,496,253,302\n\xa0 기타자본구성요소\n(91,024,253,141)\n(113,403,240,100)\n6,696,445,228\n\xa0 기타포괄손익누계액\n-\n(61,803)\n4,390,971,762\n\xa0 이익잉여금(결손금)\n(87,593,107,711)\n(40,762,026,159)\n(28,783,300,327)\n자본총계\n336,476,996,760\n110,358,936,600\n121,701,285,965\n종속기업 투자주식 평가방법\n원가법\n원가법\n지분법\n관계기업 및 공동기업 투자주식 평가방법\n원가법\n원가법\n원가법\n2. 요약 포괄손익계산서\n(2022.1.1~2022.9.30)\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n매출액\n16,786,469,939\n6,872,632,976\n11,851,408,859\n영업이익(손실)\n(43,105,304,098)\n(28,394,822,762)\n(33,226,564,017)\n당기순이익(손실)\n(47,076,109,434)\n(39,758,674,736)\n(86,264,405,992)\n기본주당순이익(손실)\n(80)\n(76)\n(1,666)\n희석주당순이익(손실)\n(80)\n(76)\n(1,666)\n']"
